Antibiotice Ia
Research Antibiotice Ia (ATB) on Bullrun: market cap RON 1.42B, P/E 211.0, dividend yield 1.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerATB
- ExchangeRO
- CountryRomania
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyRON
- Market capRON 1.42B
- P/E211.0
- Dividend yield1.0%
- Financial periodQ1 2026
- RevenueRON 136.53M
- Net incomeRON 12.56M
- Free cash flow-RON 84.01M
- Gross margin68.2%
Valuation Snapshot
latest market cap is RON 1.42B; P/E is 211.0; dividend yield is 1.0%.
Peer valuation comparison
Latest P/E is 211x versus a Healthcare sector median of 24.46x (762.6% above).
Latest dividend yield is 1.04% versus a Healthcare sector median of 2.11% (50.7% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | RON 645.28M | RON 51.77M | -RON 70.17M | 65.5% | n/a | RON 9.94M | RON 233.49M | RON 932.07M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | RON 1.42B | 211.0 | 0.9% | 0.02 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.02 RON, yield 1.0%.
About Antibiotice Ia
Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company provides generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Antibiotice Ia's market cap?
Antibiotice Ia's market capitalization is RON 1.42B.
What is Antibiotice Ia's P/E ratio?
Antibiotice Ia's price-to-earnings (P/E) ratio is 211.0.
Does Antibiotice Ia pay a dividend?
Antibiotice Ia has a dividend yield of 1.0%.
What does Antibiotice Ia do?
Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company provides generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for disinfecting surfaces and hands; and veterinary.